{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:27:06Z","timestamp":1783906026418,"version":"3.55.0"},"reference-count":139,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity and excess weight are a pandemic phenomenon in the modern world. Childhood and adolescent obesity often ends up in obesity in adults. The costs of obesity and its consequences are staggering for any society, crippling for countries in development. Childhood obesity is also widespread in Macedonia. Metabolic syndrome, dyslipidemia and carbohydrate intolerance are found in significant numbers. Parents and grandparents are often obese. Some of the children are either dysmorphic, or slightly retarded. We have already described patients with Prader-Willi syndrome, Bardet-Biedl syndrome or WAGR syndrome. A genetic screening for mutations in monogenic obesity in children with early, rapid-onset or severe obesity, severe hyperphagia, hypogonadism, intestinal dysfunction, hypopigmentation of hair and skin, postprandial hypoglycaemia, diabetes insipidus, abnormal leptin level and coexistence of lean and obese siblings in the family discovers many genetic forms of obesity. There are about 30 monogenic forms of obesity. In addition, obesity is different in ethnic groups, and the types of monogenic obesity differ. In brief, an increasing number of genes and genetic mechanisms in children continue to be discovered. This sheds new light on the molecular mechanisms of obesity and potentially gives a target for new forms of treatment.<\/jats:p>","DOI":"10.2478\/prilozi-2018-0013","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T18:17:53Z","timestamp":1524075473000},"page":"121-133","source":"Crossref","is-referenced-by-count":20,"title":["Obesity in Childhood and Adolescence, Genetic Factors"],"prefix":"10.2478","volume":"38","author":[{"given":"Marko","family":"Kostovski","sequence":"first","affiliation":[{"name":"Faculty of Medicine , University \u201cSs. Cyril and Methodius\u201d , 50 Divizija BB, 1000 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velibor","family":"Tasic","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , University \u201cSs. Cyril and Methodius\u201d , 50 Divizija BB, 1000 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Laban","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , University \u201cSs. Cyril and Methodius\u201d , 50 Divizija BB, 1000 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momir","family":"Polenakovic","sequence":"additional","affiliation":[{"name":"Macedonia Academy of Science and Arts , Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Danilovski","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , University \u201cSs. Cyril and Methodius\u201d , 50 Divizija BB, 1000 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Gucev","sequence":"additional","affiliation":[{"name":"Faculty of Medicine , University \u201cSs. Cyril and Methodius\u201d , 50 Divizija BB, 1000 Skopje , Republic of Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"2026071212051946657_j_prilozi-2018-0013_ref_001_w2aab3b7c13b1b6b1ab1ab1Aa","unstructured":"1. Memedi R, Tasic V, Nikolic E, Jancevska A, Gucev Z. Obesity in childhood and adolescence, genetic factors. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(2):85-89."},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_002_w2aab3b7c13b1b6b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11-25.10.1080\/17477160600586747","DOI":"10.1080\/17477160600586747"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_003_w2aab3b7c13b1b6b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: publichealth crisis, common sense cure. Lancet. 2002;360(9331):473\u2013482.10.1016\/S0140-6736(02)09678-2","DOI":"10.1016\/S0140-6736(02)09678-2"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_004_w2aab3b7c13b1b6b1ab1ab4Aa","unstructured":"4. Krstevska-Konstantinova M, Jancevska A, Kocova M, Gucev Z. Weight, height and puberty in a cohort of Macedonian girls. Med Arh. 2009;63(2):80-1."},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_005_w2aab3b7c13b1b6b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003\u20132006. JAMA. 2008;299(20):2401-2405.10.1001\/jama.299.20.2401","DOI":"10.1001\/jama.299.20.2401"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_006_w2aab3b7c13b1b6b1ab1ab6Aa","doi-asserted-by":"crossref","unstructured":"6. Kipping RR, Jago R, Lawlor DA. Obesity in children. Part 1: epidemiology, measurement, risk factors, and screening. BMJ. 2008;337:a1824.10.1136\/bmj.a1824","DOI":"10.1136\/bmj.a1824"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_007_w2aab3b7c13b1b6b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. Sundblom E, Petzold M, Rasmussen F, Callmer E, Lissner L. Childhood overweight and obesity prevalences levelling off in Stockholm but socioeconomic diff erences persist. Int J Obes (Lond). 2008;32(10):1525-1530.10.1038\/ijo.2008.104","DOI":"10.1038\/ijo.2008.104"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_008_w2aab3b7c13b1b6b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240-1243.10.1136\/bmj.320.7244.1240","DOI":"10.1136\/bmj.320.7244.1240"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_009_w2aab3b7c13b1b6b1ab1ab9Aa","doi-asserted-by":"crossref","unstructured":"9. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. The national health and nutrition examination surveys, 1963 to 1991. Arch Pediatr Adolesc Med. 1995;149(10):1085-1091.10.1001\/archpedi.1995.02170230039005","DOI":"10.1001\/archpedi.1995.02170230039005"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_010_w2aab3b7c13b1b6b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. Neovius MG, Linne YM, Barkeling BS, Rossner SO. Sensitivity and specificity of classification systems for fatness in adolescents. Am J Clin Nutr. 2004;80(3):597-603.10.1093\/ajcn\/80.3.597","DOI":"10.1093\/ajcn\/80.3.597"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_011_w2aab3b7c13b1b6b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. Unger RH. The hyperleptinemia of obesity regulator of caloric surpluses. Cell. 2004;117(2):145-146.10.1016\/S0092-8674(04)00339-3","DOI":"10.1016\/S0092-8674(04)00339-3"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_012_w2aab3b7c13b1b6b1ab1ac12Aa","doi-asserted-by":"crossref","unstructured":"12. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387(6636):903-1103.10.1038\/431859202122","DOI":"10.1038\/43185"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_013_w2aab3b7c13b1b6b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T-cell hyporesponsivness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093-1103.10.1172\/JCI0215693","DOI":"10.1172\/JCI0215693"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_014_w2aab3b7c13b1b6b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. Waalen, J. The genetics of human obesity. Transl Res. 2014;164(4):293-301.10.1016\/j.trsl.2014.05.01024929207","DOI":"10.1016\/j.trsl.2014.05.010"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_015_w2aab3b7c13b1b6b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009;17(1):3-13.10.1038\/ejhg.2008.165298596618781185","DOI":"10.1038\/ejhg.2008.165"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_016_w2aab3b7c13b1b6b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. Butler, MG. Prader-Willi syndrome: obesity due to genomic imprinting. Curr Genomics. 2011;12(3):204-215.10.2174\/138920211795677877313700522043168","DOI":"10.2174\/138920211795677877"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_017_w2aab3b7c13b1b6b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38:1249-1263.10.1007\/s40618-015-0312-9463025526062517","DOI":"10.1007\/s40618-015-0312-9"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_018_w2aab3b7c13b1b6b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. Sahoo T, Gaudio D, German JR, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C\/D box small nucleolar RNA cluster. Nat Genet. 2008;40(6):719-721.10.1038\/ng.158270519718500341","DOI":"10.1038\/ng.158"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_019_w2aab3b7c13b1b6b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. Jong MT, Carey AH, Caldwell KA, et al. Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. Hum Mol Genet. 1999;8(5):795-803.10.1093\/hmg\/8.5.79510196368","DOI":"10.1093\/hmg\/8.5.795"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_020_w2aab3b7c13b1b6b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. Boccaccio I, Glatt-Deeley H, Watrin F, Roeckel N, Lalande M, Muscatelli F. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum Mol Genet. 1999;8(13):2497-2505.10.1093\/hmg\/8.13.249710556298","DOI":"10.1093\/hmg\/8.13.2497"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_021_w2aab3b7c13b1b6b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. MacDonald HR, Wevrick R. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Hum Mol Genet. 1997;6(11):1873-1878.10.1093\/hmg\/6.11.18739302265","DOI":"10.1093\/hmg\/6.11.1873"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_022_w2aab3b7c13b1b6b1ab1ac22Aa","doi-asserted-by":"crossref","unstructured":"22. Farber C, Gross S, Neesen J. Buiting K. Horsthemke B. Identification of a testis-specific gene (C15orf2) in the Prader-Willi syndrome region on chromosome 15. Genomics. 2000;65(2):174-183.10.1006\/geno.2000.615810783265","DOI":"10.1006\/geno.2000.6158"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_023_w2aab3b7c13b1b6b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. Griggs J, Sinnayah P, Mathai, ML. Prader-Willi syndrome: from genetics to behaviour, with special focus on appetite treatments. Neurosci Biobehav Rev. 2015;59:155-172.10.1016\/j.neubiorev.2015.10.00326475993","DOI":"10.1016\/j.neubiorev.2015.10.003"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_024_w2aab3b7c13b1b6b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. M\u2019Hamdi O, Ouertani I, Chaabouni-Bouhamed H. Update on the genetics of Bardet-Biedl syndrome. Mol Syndromol. 2014;5(2):51-56.10.1159\/000357054397722324715851","DOI":"10.1159\/000357054"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_025_w2aab3b7c13b1b6b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. Forsythe E, Beales PL. Bardet-Biedl syndrome. Eur J Hum Genet. 2013;21(1):8\u20131310.1038\/ejhg.2012.115352219622713813","DOI":"10.1038\/ejhg.2012.115"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_026_w2aab3b7c13b1b6b1ab1ac26Aa","doi-asserted-by":"crossref","unstructured":"26. Brown JM, Witman GB. Cilia and diseases. Bioscience. 2014;64:1126-1137.10.1093\/biosci\/biu174442026125960570","DOI":"10.1093\/biosci\/biu174"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_027_w2aab3b7c13b1b6b1ab1ac27Aa","doi-asserted-by":"crossref","unstructured":"27. Seo S, Guo DF, Bugge K., Morgan DA, Rahmouni K, SheffieldnVC. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet. 2009;18(7):1323-1331.10.1093\/hmg\/ddp031265577319150989","DOI":"10.1093\/hmg\/ddp031"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_028_w2aab3b7c13b1b6b1ab1ac28Aa","doi-asserted-by":"crossref","unstructured":"28. Ristoska Bojkovska N, Spahiu L, Janchevska A, Gucev ZS, Tasic V. Renal dysplasia in Bardet-Biedl syndrome. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(1):211-215.10.1515\/prilozi-2015-0048","DOI":"10.1515\/prilozi-2015-0048"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_029_w2aab3b7c13b1b6b1ab1ac29Aa","doi-asserted-by":"crossref","unstructured":"29. Marshall JD, Bronson RT, Collin GB, et al. New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005;165(6):675-683.10.1001\/archinte.165.6.67515795345","DOI":"10.1001\/archinte.165.6.675"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_030_w2aab3b7c13b1b6b1ab1ac30Aa","unstructured":"30. Pagon RA, Adam MP, Ardinger HH, et al., editors. Seattle (WA): University of Washington, Seattle; 1993-2017."},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_031_w2aab3b7c13b1b6b1ab1ac31Aa","doi-asserted-by":"crossref","unstructured":"31. Collin GB, Marshall JD, Ikeda A, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet. 2002;31(1):74-78.10.1038\/ng86711941369","DOI":"10.1038\/ng867"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_032_w2aab3b7c13b1b6b1ab1ac32Aa","doi-asserted-by":"crossref","unstructured":"32. Wang L, Shoemaker AH. Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study. Int J Pediatr Endocrinol. 2014;2014(1):21.10.1186\/1687-9856-2014-21420477725337124","DOI":"10.1186\/1687-9856-2014-21"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_033_w2aab3b7c13b1b6b1ab1ac33Aa","doi-asserted-by":"crossref","unstructured":"33. Turan S, Bastepe M. GNAS spectrum of disorders. Curr Osteoporos Rep. 2015;13(3):146-158.10.1007\/s11914-015-0268-x441743025851935","DOI":"10.1007\/s11914-015-0268-x"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_034_w2aab3b7c13b1b6b1ab1ac34Aa","doi-asserted-by":"crossref","unstructured":"34. Levine MA. An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opi Endocrinol Diabetes Obes. 2012;19(6):443-451.10.1097\/MED.0b013e32835a255c367953523076042","DOI":"10.1097\/MED.0b013e32835a255c"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_035_w2aab3b7c13b1b6b1ab1ac35Aa","doi-asserted-by":"crossref","unstructured":"35. Rivera-Brugues N, Albrecht B, Wieczorek D, et al. Cohen syndrome diagnosis using whole genome arrays. J Med Genet. 2011;48(2):136-140.10.1136\/jmg.2010.08220620921020","DOI":"10.1136\/jmg.2010.082206"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_036_w2aab3b7c13b1b6b1ab1ac36Aa","doi-asserted-by":"crossref","unstructured":"36. Kolehmainen J, Black GC, Saarinen A, et al. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet. 2003;72(6):1359-1369.10.1086\/375454118029812730828","DOI":"10.1086\/375454"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_037_w2aab3b7c13b1b6b1ab1ac37Aa","doi-asserted-by":"crossref","unstructured":"37. Miyake N, Koshimizu E, Okamoto N, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet. 2013;161A(9):2234-2243.10.1002\/ajmg.a.3607223913813","DOI":"10.1002\/ajmg.a.36072"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_038_w2aab3b7c13b1b6b1ab1ac38Aa","doi-asserted-by":"crossref","unstructured":"38. Ng SB, Bigham AW, Buckingham K.J et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42(9):790-793.10.1038\/ng.646293002820711175","DOI":"10.1038\/ng.646"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_039_w2aab3b7c13b1b6b1ab1ac39Aa","doi-asserted-by":"crossref","unstructured":"39. Lederer D, Grisart B, Digilio MC, et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet. 2012;90(1):119-124.10.1016\/j.ajhg.2011.11.021325787822197486","DOI":"10.1016\/j.ajhg.2011.11.021"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_040_w2aab3b7c13b1b6b1ab1ac40Aa","doi-asserted-by":"crossref","unstructured":"40. Paulussen AD, Stegmann AP, Blok MJ, et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum Mutat. 2011;32(2):E2018-E2025.10.1002\/humu.2141621280141","DOI":"10.1002\/humu.21416"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_041_w2aab3b7c13b1b6b1ab1ac41Aa","doi-asserted-by":"crossref","unstructured":"41. Turner G, Lower KM, White SM, et al. The clinical picture of the Borjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations. Clin Genet. 2004;65(3):226-232.10.1111\/j.0009-9163.2004.00215.x14756673","DOI":"10.1111\/j.0009-9163.2004.00215.x"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_042_w2aab3b7c13b1b6b1ab1ac42Aa","doi-asserted-by":"crossref","unstructured":"42. Lower KM, Turner G, Kerr BA, et al. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet. 2002;32(4):661-665.10.1038\/ng104012415272","DOI":"10.1038\/ng1040"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_043_w2aab3b7c13b1b6b1ab1ac43Aa","doi-asserted-by":"crossref","unstructured":"43. Cohen DM, Green JG, Miller J, Gorlin RJ, Reed JA. Acrocephalopolysyndactyly type II\u2013Carpenter syndrome: clinical spectrum and an attempt at unification with Goodman and Summit syndromes. Am J Med Genet. 1987;28(2):311-324.10.1002\/ajmg.13202802083322002","DOI":"10.1002\/ajmg.1320280208"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_044_w2aab3b7c13b1b6b1ab1ac44Aa","doi-asserted-by":"crossref","unstructured":"44. Alessandri JL, Dagoneau N, Laville JM, Baruteau J, Hebert JC, Cormier-Daire V. RAB23 mutation in a large family from Comoros Islands with Carpenter syndrome. Am J Med Genet. 2010;152A(4):982-986.10.1002\/ajmg.a.3332720358613","DOI":"10.1002\/ajmg.a.33327"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_045_w2aab3b7c13b1b6b1ab1ac45Aa","doi-asserted-by":"crossref","unstructured":"45. Jenkins D, Baynam G, Catte L. Carpenter syndrome: extended RAB23 mutation spectrum and analysis of nonsense-mediated mRNA decay. Hum Mutat. 2011;32(4):E2069-E2078.10.1002\/humu.21457342986821412941","DOI":"10.1002\/humu.21457"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_046_w2aab3b7c13b1b6b1ab1ac46Aa","unstructured":"46. Chen L, Mullegama SV, Alaimo JT, Elsea SH. Smith-Magenis syndrome and its circadian influence on development, behavior, and obesity \u2013 own experience. Dev Period Med. 2015;19(2):149-156."},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_047_w2aab3b7c13b1b6b1ab1ac47Aa","doi-asserted-by":"crossref","unstructured":"47. Han JC, Liu QR, Jones M, Levinn RL, et al. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med. 2008;359(9):918-927.10.1056\/NEJMoa0801119255370418753648","DOI":"10.1056\/NEJMoa0801119"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_048_w2aab3b7c13b1b6b1ab1ac48Aa","doi-asserted-by":"crossref","unstructured":"48. Rodriguez-Lopez R, Perez JM, Balsera AM, et al. The modifier effect of the BDNF gene in the phenotype of the WAGRO syndrome. Gene. 2013;516(2):285-290.10.1016\/j.gene.2012.11.07323266638","DOI":"10.1016\/j.gene.2012.11.073"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_049_w2aab3b7c13b1b6b1ab1ac49Aa","doi-asserted-by":"crossref","unstructured":"49. Gucev Z, Muratovska O, Laban N, et al. Billateral polycystic kidneys in a girl with WAGR syndrome. Indian J Pediatr. 2011;78(10):1290-1292.10.1007\/s12098-011-0457-221660403","DOI":"10.1007\/s12098-011-0457-2"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_050_w2aab3b7c13b1b6b1ab1ac50Aa","doi-asserted-by":"crossref","unstructured":"50. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387(6636):903-908.10.1038\/431859202122","DOI":"10.1038\/43185"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_051_w2aab3b7c13b1b6b1ab1ac51Aa","doi-asserted-by":"crossref","unstructured":"51. Gibson WT, Farooqi IS, Moreau M, et al. Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab. 2004;89(10):4821-4826.10.1210\/jc.2004-037615472169","DOI":"10.1210\/jc.2004-0376"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_052_w2aab3b7c13b1b6b1ab1ac52Aa","doi-asserted-by":"crossref","unstructured":"52. Mazen I, El-Gammal M, Abdel-Hamid M, Amr K. A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient. Mol Genet Metab. 2009;97(4):305-308.10.1016\/j.ymgme.2009.04.00219427251","DOI":"10.1016\/j.ymgme.2009.04.002"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_053_w2aab3b7c13b1b6b1ab1ac53Aa","doi-asserted-by":"crossref","unstructured":"53. Wabitsch M, Funcke JB, Lennerz B, et al. Biologically inactive leptin and early-onset extreme obesity. N Engl J Med. 2015;372:48-54.10.1056\/NEJMoa140665325551525","DOI":"10.1056\/NEJMoa1406653"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_054_w2aab3b7c13b1b6b1ab1ac54Aa","doi-asserted-by":"crossref","unstructured":"54. Cl\u00b4ement K, Vaisse C, Lahlou N. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392(6674):398-401.10.1038\/329119537324","DOI":"10.1038\/32911"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_055_w2aab3b7c13b1b6b1ab1ac55Aa","doi-asserted-by":"crossref","unstructured":"55. Farooqi IS, Wangensteen T, Collins S. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med. 2007;356(3):237-247.10.1056\/NEJMoa063988267019717229951","DOI":"10.1056\/NEJMoa063988"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_056_w2aab3b7c13b1b6b1ab1ac56Aa","doi-asserted-by":"crossref","unstructured":"56. Saeed S, Bonnefond A, Manzoor J, et al. Novel LEPR mutations in obese Pakistani children identified by PCR-based enrichment and next generation sequencing. Obesity. 2014;22(4):1112-1117.10.1002\/oby.2066724319006","DOI":"10.1002\/oby.20667"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_057_w2aab3b7c13b1b6b1ab1ac57Aa","doi-asserted-by":"crossref","unstructured":"57. Huvenne H, Beyec J, P\u00b4epin D, et al. Seven novel deleterious LEPR mutations found in early-onset obesity: a \u0394Exon6-8 shared by subjects from Reunion Island, France, suggests a founder effect. J Clin Endocrinol Metab. 2015;100(5):E757-E66.10.1210\/jc.2015-103625751111","DOI":"10.1210\/jc.2015-1036"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_058_w2aab3b7c13b1b6b1ab1ac58Aa","doi-asserted-by":"crossref","unstructured":"58. Farooqi, IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093-1103.10.1172\/JCI0215693","DOI":"10.1172\/JCI0215693"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_059_w2aab3b7c13b1b6b1ab1ac59Aa","doi-asserted-by":"crossref","unstructured":"59. Simonds SE, Pryor JT, Ravussin E, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159(6):1404-1416.10.1016\/j.cell.2014.10.058425949125480301","DOI":"10.1016\/j.cell.2014.10.058"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_060_w2aab3b7c13b1b6b1ab1ac60Aa","doi-asserted-by":"crossref","unstructured":"60. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341:879-884.10.1056\/NEJM19990916341120410486419","DOI":"10.1056\/NEJM199909163411204"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_061_w2aab3b7c13b1b6b1ab1ac61Aa","doi-asserted-by":"crossref","unstructured":"61. Doche ME, Bochukova EG, Su HW, et al. Human SH2B1 mutations are associated with maladaptive behaviors and obesity. J Clin Invest. 2012; 122(12):4732-4736.10.1172\/JCI62696353353523160192","DOI":"10.1172\/JCI62696"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_062_w2aab3b7c13b1b6b1ab1ac62Aa","doi-asserted-by":"crossref","unstructured":"62. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19(2):155-157.10.1038\/5099620771","DOI":"10.1038\/509"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_063_w2aab3b7c13b1b6b1ab1ac63Aa","doi-asserted-by":"crossref","unstructured":"63. Farooqi IS, Drop S, Clements A, et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes. 2006; 55(9):2549-2553.10.2337\/db06-021416936203","DOI":"10.2337\/db06-0214"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_064_w2aab3b7c13b1b6b1ab1ac64Aa","doi-asserted-by":"crossref","unstructured":"64. Krude H, Biebermann H, Gruters A. Mutations in the human proopiomelanocortin gene. Ann N Y Acad Sci. 2003;994:233-239.10.1111\/j.1749-6632.2003.tb03185.x12851321","DOI":"10.1111\/j.1749-6632.2003.tb03185.x"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_065_w2aab3b7c13b1b6b1ab1ac65Aa","doi-asserted-by":"crossref","unstructured":"65. Ozen S, Ozcan N, Ucar SK, Goksen D, Darcan S. Unexpected clinical features in a female patient with proopiomelanocortin (POMC) deficiency. J Pediatr Endocrinol Metab. 2015;28(5-6):691-694.10.1515\/jpem-2014-032425503863","DOI":"10.1515\/jpem-2014-0324"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_066_w2aab3b7c13b1b6b1ab1ac66Aa","doi-asserted-by":"crossref","unstructured":"66. Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1\/3. J Clin Endocrinol Metab. 2007;92(9):3369-3373.10.1210\/jc.2007-068717595246","DOI":"10.1210\/jc.2007-0687"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_067_w2aab3b7c13b1b6b1ab1ac67Aa","doi-asserted-by":"crossref","unstructured":"67. Jackson RS, Creemers JW, Farooqi IS. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003:112(10):1550-1560.10.1172\/JCI200318784","DOI":"10.1172\/JCI200318784"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_068_w2aab3b7c13b1b6b1ab1ac68Aa","doi-asserted-by":"crossref","unstructured":"68. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16(3):303\u201330610.1038\/ng0797-3039207799","DOI":"10.1038\/ng0797-303"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_069_w2aab3b7c13b1b6b1ab1ac69Aa","doi-asserted-by":"crossref","unstructured":"69. Frank GR., Fox J, Candela N, et al. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Mol Genet Metab. 2013;110(1-2):191-194.10.1016\/j.ymgme.2013.04.005375984523800642","DOI":"10.1016\/j.ymgme.2013.04.005"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_070_w2aab3b7c13b1b6b1ab1ac70Aa","doi-asserted-by":"crossref","unstructured":"70. Mart\u00edn MG, Lindberg I, Solorzano-Vargas RS, et al. Congenital Proprotein Convertase 1\/3 Deficiency Causes Malabsorptive Diarrhea and other Endocrinopathies in a Pediatric Cohort. Gastroenterology. 2013;145(1):138-148.10.1053\/j.gastro.2013.03.048371913323562752","DOI":"10.1053\/j.gastro.2013.03.048"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_071_w2aab3b7c13b1b6b1ab1ac71Aa","doi-asserted-by":"crossref","unstructured":"71. Yourshaw M, Solorzano-Vargas RS, Pickett LA, et al. Exome Sequencing Finds a Novel PCSK1 Mutation in a Child With Generalized Malabsorptive Diarrhea and Diabetes Insipidus. J Pediatr Gastroenterol Nutr. 2013;57(6):759-767.10.1097\/MPG.0b013e3182a8ae6c417006224280991","DOI":"10.1097\/MPG.0b013e3182a8ae6c"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_072_w2aab3b7c13b1b6b1ab1ac72Aa","doi-asserted-by":"crossref","unstructured":"72. Philippe J, Stijnen P, Meyre D, et al. A nonsense loss-of-function mutation in PCSK1contributes to dominantly inherited human obesity. Int J Obes. 2015;39(2):295-302.10.1038\/ijo.2014.9624890885","DOI":"10.1038\/ijo.2014.96"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_073_w2aab3b7c13b1b6b1ab1ac73Aa","doi-asserted-by":"crossref","unstructured":"73. Dubern B, Bisbis S, Talbaoui H, et al. Homozygous null mutation of the melanocortin-4 receptor and severe early-onset obesity. J Pediatr. 2007;150(6):613-617.e1.10.1016\/j.jpeds.2007.01.04117517245","DOI":"10.1016\/j.jpeds.2007.01.041"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_074_w2aab3b7c13b1b6b1ab1ac74Aa","doi-asserted-by":"crossref","unstructured":"74. Garg G, Kumar J, McGuigan FE, et al. Variation in the MC4R Gene Is Associated with Bone Phenotypes in Elderly Swedish Women. Devaney J, ed. PLoS One. 2014;9(2):e88565.10.1371\/journal.pone.0088565391644024516669","DOI":"10.1371\/journal.pone.0088565"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_075_w2aab3b7c13b1b6b1ab1ac75Aa","doi-asserted-by":"crossref","unstructured":"75. Timpson NJ, Sayers A, Davey-Smith G, Tobias JH. How does body fat influence bone mass in childhood? A Mendelian randomization approach. J Bone Miner Res. 2009;24(3):522-533.10.1359\/jbmr.081109287516519016587","DOI":"10.1359\/jbmr.081109"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_076_w2aab3b7c13b1b6b1ab1ac76Aa","doi-asserted-by":"crossref","unstructured":"76. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant andrecessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 2000;106(2):271-279.10.1172\/JCI9397","DOI":"10.1172\/JCI9397"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_077_w2aab3b7c13b1b6b1ab1ac77Aa","doi-asserted-by":"crossref","unstructured":"77. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O\u2019Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(12):1085-1095.10.1056\/NEJMoa022050","DOI":"10.1056\/NEJMoa022050"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_078_w2aab3b7c13b1b6b1ab1ac78Aa","doi-asserted-by":"crossref","unstructured":"78. Yeo GS, Conie Hung CC, Rochford, J, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci. 2004;7(11):1187-1189.10.1038\/nn1336","DOI":"10.1038\/nn1336"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_079_w2aab3b7c13b1b6b1ab1ac79Aa","doi-asserted-by":"crossref","unstructured":"79. Gray J, Yeo GS, Cox JJ, et al. Hyperphagia, severe obesity, impaired cognitiven function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes. 2006;55(12):3366-3371.10.2337\/db06-0550","DOI":"10.2337\/db06-0550"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_080_w2aab3b7c13b1b6b1ab1ac80Aa","doi-asserted-by":"crossref","unstructured":"80. Michaud JL, DeRossi C, May NR, Holdener BC, Fan CM. ARNT2 acts as the dimerization partner of SIM1 for the development of the hypothalamus. Mech Dev. 2000;90(2):253-261.10.1016\/S0925-4773(99)00328-7","DOI":"10.1016\/S0925-4773(99)00328-7"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_081_w2aab3b7c13b1b6b1ab1ac81Aa","doi-asserted-by":"crossref","unstructured":"81. Michaud JL, Rosenquist T, May NR, Fan CM. Development of neuroendocrine lineages requires the bHLH\u2013PAS transcription factor SIM1. Genes Dev. 1998;12(20):3264-3275.10.1101\/gad.12.20.32643172169784500","DOI":"10.1101\/gad.12.20.3264"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_082_w2aab3b7c13b1b6b1ab1ac82Aa","doi-asserted-by":"crossref","unstructured":"82. Michaud JL, Boucher F, Melnyk A. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet. 2001;10(14): 1465-1473.10.1093\/hmg\/10.14.146511448938","DOI":"10.1093\/hmg\/10.14.1465"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_083_w2aab3b7c13b1b6b1ab1ac83Aa","doi-asserted-by":"crossref","unstructured":"83. Holder JL, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet. 2000;9:101-108.10.1093\/hmg\/9.1.10110587584","DOI":"10.1093\/hmg\/9.1.101"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_084_w2aab3b7c13b1b6b1ab1ac84Aa","doi-asserted-by":"crossref","unstructured":"84. Bonnefond A, Raimondo A, Stutzmann F, et al. Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi\u2013like features. J Clin Invest. 2013;123(7):3037-3041.10.1172\/JCI68035369655923778136","DOI":"10.1172\/JCI68035"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_085_w2aab3b7c13b1b6b1ab1ac85Aa","doi-asserted-by":"crossref","unstructured":"85. Montagne L, Raimondo A, Delobel B, et al. Identification of two novel loss-of-function SIM1 mutations in two overweight children with developmental delay. Obesity. 2014;22(12):2621-2624.10.1002\/oby.2088625234154","DOI":"10.1002\/oby.20886"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_086_w2aab3b7c13b1b6b1ab1ac86Aa","doi-asserted-by":"crossref","unstructured":"86. Ramachandrappa S, Raimondo A, Cali AMG, et al. Rare variants in single-minded 1 (SIM1) are associated with severe obesity. J Clin Invest. 2013;123(7):3042-3050.10.1172\/JCI68016369655823778139","DOI":"10.1172\/JCI68016"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_087_w2aab3b7c13b1b6b1ab1ac87Aa","doi-asserted-by":"crossref","unstructured":"87. Pearce LR, Atanassova N, Banton MC, et al. KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation. Cell. 2013;155(4):765-777.10.1016\/j.cell.2013.09.058389874024209692","DOI":"10.1016\/j.cell.2013.09.058"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_088_w2aab3b7c13b1b6b1ab1ac88Aa","doi-asserted-by":"crossref","unstructured":"88. Borman AD, Pearce LR, Mackay DS, et al. A Homozygous Mutation in the TUB Gene Associated with Retinal Dystrophy and Obesity. Hum Mutat. 2014;35(3):289-293.10.1002\/humu.22482428401824375934","DOI":"10.1002\/humu.22482"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_089_w2aab3b7c13b1b6b1ab1ac89Aa","doi-asserted-by":"crossref","unstructured":"89. Choquet H, Meyre D. Molecular Basis of Obesity: Current Status and Future Prospects. Curr Genomics. 2011;12(3):154-168.10.2174\/138920211795677921313700122043164","DOI":"10.2174\/138920211795677921"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_090_w2aab3b7c13b1b6b1ab1ac90Aa","doi-asserted-by":"crossref","unstructured":"90. Choquet H, Meyre D. Genetics of Obesity: What have we Learned? Curr Genomics. 2011;12(3):169-179.10.2174\/138920211795677895313700222043165","DOI":"10.2174\/138920211795677895"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_091_w2aab3b7c13b1b6b1ab1ac91Aa","doi-asserted-by":"crossref","unstructured":"91. Stutzmann F, Tan K, Vatin V, et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes. 2008;57(9):2511-2518.10.2337\/db08-0153251850418559663","DOI":"10.2337\/db08-0153"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_092_w2aab3b7c13b1b6b1ab1ac92Aa","doi-asserted-by":"crossref","unstructured":"92. Stanikova D, Surova M, Buzga M, et al. Age of obesity onset in MC4R mutation carriers. Endocr Regul. 2014;49(3):137-140.10.4149\/endo_2015_03_13726238496","DOI":"10.4149\/endo_2015_03_137"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_093_w2aab3b7c13b1b6b1ab1ac93Aa","doi-asserted-by":"crossref","unstructured":"93. Biebermann H, Castaneda TR, van Landeghem F, et al. A role for \u03b2-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 2006;3(2):141-146.10.1016\/j.cmet.2006.01.00716459315","DOI":"10.1016\/j.cmet.2006.01.007"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_094_w2aab3b7c13b1b6b1ab1ac94Aa","doi-asserted-by":"crossref","unstructured":"94. Challis BG, Pritchard LE, Creemers JW, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 2002;11(17):1997-2004.10.1093\/hmg\/11.17.199712165561","DOI":"10.1093\/hmg\/11.17.1997"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_095_w2aab3b7c13b1b6b1ab1ac95Aa","doi-asserted-by":"crossref","unstructured":"95. Lee YS, Challis BG, Thompson DA, et al. A POMC variant implicates \u03b2-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3(2):135-140.10.1016\/j.cmet.2006.01.00616459314","DOI":"10.1016\/j.cmet.2006.01.006"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_096_w2aab3b7c13b1b6b1ab1ac96Aa","doi-asserted-by":"crossref","unstructured":"96. Farooqi IS, Keogh JM, Kamath S, et al. Metabolism: partial leptin deficiency and human adiposity. Nature. 2001;414(6859):34-35.10.1038\/3510211211689931","DOI":"10.1038\/35102112"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_097_w2aab3b7c13b1b6b1ab1ac97Aa","doi-asserted-by":"crossref","unstructured":"97. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med. 2003;54:453-471.10.1146\/annurev.med.54.101601.15240312414915","DOI":"10.1146\/annurev.med.54.101601.152403"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_098_w2aab3b7c13b1b6b1ab1ac98Aa","doi-asserted-by":"crossref","unstructured":"98. Meyre D, Bouatia-Naji N, Tounian A, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 2005;37(8):863-867.10.1038\/ng1604200080416025115","DOI":"10.1038\/ng1604"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_099_w2aab3b7c13b1b6b1ab1ac99Aa","doi-asserted-by":"crossref","unstructured":"99. Meyre D, Lecoeur C, Delplanque J, et al. A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-q23.2. Diabetes. 2004;53(3):803-811.10.2337\/diabetes.53.3.80314988267","DOI":"10.2337\/diabetes.53.3.803"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_100_w2aab3b7c13b1b6b1ab1ad100Aa","unstructured":"100. Wang R, Zhou D, Xi B, et al. ENPP1\/PC-1 gene K121Q polymorphism is associated with obesity in European adult populations: evidence from a meta-analysis involving 24,324 subjects. Biomed Environ Sci. 2011;24(2):200-206."},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_101_w2aab3b7c13b1b6b1ab1ad101Aa","doi-asserted-by":"crossref","unstructured":"101. Warrington NM, Howe LD, Paternoster L, et al. A genome-wide association study of body mass index across early life and childhood. Int J Epidemiol. 2015;44(2):700-712.10.1093\/ije\/dyv077446979825953783","DOI":"10.1093\/ije\/dyv077"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_102_w2aab3b7c13b1b6b1ab1ad102Aa","doi-asserted-by":"crossref","unstructured":"102. Bradfield JP, Taal HR, Timpson NJ, et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet. 2012;44(5):526-531.10.1038\/ng.2247337010022484627","DOI":"10.1038\/ng.2247"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_103_w2aab3b7c13b1b6b1ab1ad103Aa","unstructured":"103. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206.10.1038\/nature14177438221125673413"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_104_w2aab3b7c13b1b6b1ab1ad104Aa","doi-asserted-by":"crossref","unstructured":"104. Meyre D, Delplanque J, Chevre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009;41(2):157-159.10.1038\/ng.30119151714","DOI":"10.1038\/ng.301"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_105_w2aab3b7c13b1b6b1ab1ad105Aa","doi-asserted-by":"crossref","unstructured":"105. Li A, Meyre D. Jumping on the Train of Personalized Medicine: A Primer for Non-Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area. Curr Psychiatry Rev. 2014;10(2):118-132.10.2174\/1573400510666140630170549428788425598768","DOI":"10.2174\/1573400510666140630170549"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_106_w2aab3b7c13b1b6b1ab1ad106Aa","doi-asserted-by":"crossref","unstructured":"106. Bonnefond A, Philippe J, Durand E, et al. Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing. Diabetes Care. 2014;37(2):460-467.10.2337\/dc13-069824041679","DOI":"10.2337\/dc13-0698"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_107_w2aab3b7c13b1b6b1ab1ad107Aa","doi-asserted-by":"crossref","unstructured":"107. Philippe J, Derhourhi M, Durand E, et al. What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity? Brusgaard K, ed. PLoS One. 2015;10(11):e0143373.10.1371\/journal.pone.0143373465789726599467","DOI":"10.1371\/journal.pone.0143373"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_108_w2aab3b7c13b1b6b1ab1ad108Aa","doi-asserted-by":"crossref","unstructured":"108. Hinney A, Wolters B, P\u00fctter C, et al. J Pediatr Endocrinol Metab. 2013;26(11-12):1209-1213.10.1515\/jpem-2013-017923843577","DOI":"10.1515\/jpem-2013-0179"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_109_w2aab3b7c13b1b6b1ab1ad109Aa","doi-asserted-by":"crossref","unstructured":"109. Reinehr T, Wolters B, Roth CL, Hinney A. (2014) FTO gene: association to weight regain after lifestyle intervention in overweight children. Horm Res Paediatr. 2014;81(6):391-396.10.1159\/00035832824819256","DOI":"10.1159\/000358328"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_110_w2aab3b7c13b1b6b1ab1ad110Aa","doi-asserted-by":"crossref","unstructured":"110. Qi L. Gene\u2013diet interaction and weight loss. Curr Opinion Lipid. 2014;25(1):27-34.10.1097\/MOL.0000000000000037533019824345984","DOI":"10.1097\/MOL.0000000000000037"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_111_w2aab3b7c13b1b6b1ab1ad111Aa","doi-asserted-by":"crossref","unstructured":"111. Le Beyec J, Cugnet-Anceau C, Pepin D, et al. Homozygous leptin receptor mutation due to uniparental disomy of chromosome 1: response to bariatric surgery. J Clin Endocrinol Metab. 2013;98(2):E397-E402.10.1210\/jc.2012-277923275530","DOI":"10.1210\/jc.2012-2779"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_112_w2aab3b7c13b1b6b1ab1ad112Aa","doi-asserted-by":"crossref","unstructured":"112. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C. Weight Loss after Roux-en-Y Gastric Bypass in Obese Patients Heterozygous for MC4R Mutations. Obes Surg. 2011;21(7):930-934.10.1007\/s11695-010-0295-8311979820957447","DOI":"10.1007\/s11695-010-0295-8"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_113_w2aab3b7c13b1b6b1ab1ad113Aa","doi-asserted-by":"crossref","unstructured":"113. Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 Receptor Signaling Is Required for Weight Loss after Gastric Bypass Surgery. J Clin Endocrinol Metabol. 2012;97(6):E1023-E1031.10.1210\/jc.2011-3432338741222492873","DOI":"10.1210\/jc.2011-3432"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_114_w2aab3b7c13b1b6b1ab1ad114Aa","doi-asserted-by":"crossref","unstructured":"114. Valette M, Poitou C, Le Beyec J, Bouillot J-L, Clement K, Czernichow S. Melanocortin-4 Receptor Mutations and Polymorphisms Do Not Affect Weight Loss after Bariatric Surgery. Folli F, ed. PLoS One. 2012;7(11):e48221.10.1371\/journal.pone.0048221350404523185251","DOI":"10.1371\/journal.pone.0048221"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_115_w2aab3b7c13b1b6b1ab1ad115Aa","doi-asserted-by":"crossref","unstructured":"115. Meyre D, Froguel P, Horber FF, Kral JG. Comment On: Valette et al. Melanocortin-4 Receptor Mutations and Polymorphisms Do Not Affect Weight Loss after Bariatric Surgery. PLoS One. 2012;7(11):E48221. Folli F, ed. PLoS One. 2014;9(3):e93324.10.1371\/journal.pone.0093324","DOI":"10.1371\/journal.pone.0093324"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_116_w2aab3b7c13b1b6b1ab1ad116Aa","doi-asserted-by":"crossref","unstructured":"116. Moore BS, Mirshahi UL, Yost EA, et al. Long-Term Weight-Loss in Gastric Bypass Patients Carrying Melanocortin 4 Receptor Variants. L\u00f3pez M, ed. PLoS One. 2014;9(4):e93629.10.1371\/journal.pone.0093629397631824705671","DOI":"10.1371\/journal.pone.0093629"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_117_w2aab3b7c13b1b6b1ab1ad117Aa","doi-asserted-by":"crossref","unstructured":"117. Sarzynski MA, Jacobson P, Rankinen, T, et al. Associations of markers in 11 obesity candidate genes withmaximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes. 2011;35(5):676-683.10.1038\/ijo.2010.16620733583","DOI":"10.1038\/ijo.2010.166"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_118_w2aab3b7c13b1b6b1ab1ad118Aa","doi-asserted-by":"crossref","unstructured":"118. Hatoum IJ, Greenawalt DM, Cotsapas C, Daly MJ, Reitman ML, Kaplan LM. Weight Loss after Gastric Bypass Is Associated with a Variant at 15q26.1. Am J Hum Genet. 2013;92(5):827-834.10.1016\/j.ajhg.2013.04.009364464223643386","DOI":"10.1016\/j.ajhg.2013.04.009"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_119_w2aab3b7c13b1b6b1ab1ad119Aa","doi-asserted-by":"crossref","unstructured":"119. Fujioka K. Safety and tolerability of medications approved for chronic weight management. Obesity. 2015;23(Suppl 1):S7-S11.10.1002\/oby.2109425900872","DOI":"10.1002\/oby.21094"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_120_w2aab3b7c13b1b6b1ab1ad120Aa","doi-asserted-by":"crossref","unstructured":"120. Lazary J, Juhasz G, Hunyady L, Bagdy G. Personalized medicine can pave the way for the safe use of CB(1) receptor antagonists. Trends Pharmacol Sci. 2011;32(5):270-280.10.1016\/j.tips.2011.02.01321497918","DOI":"10.1016\/j.tips.2011.02.013"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_121_w2aab3b7c13b1b6b1ab1ad121Aa","doi-asserted-by":"crossref","unstructured":"121. Bjorge T, Engeland A, Tverdal A, Smith GD. Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol. 2008;168(1):30-37.10.1093\/aje\/kwn09618477652","DOI":"10.1093\/aje\/kwn096"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_122_w2aab3b7c13b1b6b1ab1ad122Aa","doi-asserted-by":"crossref","unstructured":"122. Gordon JE, Hughes MS, Shepherd K, et al. Obstructive sleep apnoea syndrome in morbidly obese children with tibia vara. J Bone Joint Surg Br. 2006;88(1):100-103.10.1302\/0301-620X.88B1.1691816365129","DOI":"10.1302\/0301-620X.88B1.16918"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_123_w2aab3b7c13b1b6b1ab1ad123Aa","doi-asserted-by":"crossref","unstructured":"123. Murray AW, Wilson NI. Changing incidence of slipped capital femoral epiphysis: a relationship with obesity? J Bone Joint Surg Br. 2008;90(1):92-94.10.1302\/0301-620X.90B1.19502","DOI":"10.1302\/0301-620X.90B1.19502"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_124_w2aab3b7c13b1b6b1ab1ad124Aa","doi-asserted-by":"crossref","unstructured":"124. Timpson NJ, Sayers A, Davey-Smith G, Tobias JH. How does body fat influence bone mass in childhood? A Mendelian randomization approach. J Bone Miner Res. 2009;24(3):522-533.10.1359\/jbmr.081109287516519016587","DOI":"10.1359\/jbmr.081109"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_125_w2aab3b7c13b1b6b1ab1ad125Aa","doi-asserted-by":"crossref","unstructured":"125. Tirosh A, Shai I, Afek A, Dubnov-Raz G, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011;364(14):1315-1325.10.1056\/NEJMoa1006992493925921470009","DOI":"10.1056\/NEJMoa1006992"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_126_w2aab3b7c13b1b6b1ab1ad126Aa","doi-asserted-by":"crossref","unstructured":"126. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307(5):483-490.10.1001\/jama.2012.40636245222253364","DOI":"10.1001\/jama.2012.40"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_127_w2aab3b7c13b1b6b1ab1ad127Aa","doi-asserted-by":"crossref","unstructured":"127. Calcaterra V, Klersy C, Muratori T, et al. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf). 2008;68(6):868-872.10.1111\/j.1365-2265.2007.03115.x17980007","DOI":"10.1111\/j.1365-2265.2007.03115.x"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_128_w2aab3b7c13b1b6b1ab1ad128Aa","doi-asserted-by":"crossref","unstructured":"128. Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009;123(1):84-88.10.1542\/peds.2008-014619117864","DOI":"10.1542\/peds.2008-0146"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_129_w2aab3b7c13b1b6b1ab1ad129Aa","doi-asserted-by":"crossref","unstructured":"129. Bau AM, Ernert A, Schenk L, et al. Is there a further acceleration in the age at onset of menarche? A cross-sectional study in 1840 school children focusing on age and bodyweight at the onset of menarche. Eur J Endocrinol. 2009;160(1):107-113.10.1530\/EJE-08-059418974233","DOI":"10.1530\/EJE-08-0594"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_130_w2aab3b7c13b1b6b1ab1ad130Aa","doi-asserted-by":"crossref","unstructured":"130. Mamun AA, Hayatbakhsh MR, O\u2019Callaghan M, Williams G, Najman J. Early overweight and pubertal maturation\u2014pathways of association with young adults\u2019 overweight: a longitudinal study. Int J Obes (Lond). 2009;33(1):14-20.10.1038\/ijo.2008.22018982007","DOI":"10.1038\/ijo.2008.220"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_131_w2aab3b7c13b1b6b1ab1ad131Aa","doi-asserted-by":"crossref","unstructured":"131. Denzer C, Weibel A, Muche R, Karges B, Sorgo W, Wabitsch M. Pubertal development in obese children and adolescents. Int J Obes (Lond). 2007;31(10):1509-1519.10.1038\/sj.ijo.080369117653066","DOI":"10.1038\/sj.ijo.0803691"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_132_w2aab3b7c13b1b6b1ab1ad132Aa","doi-asserted-by":"crossref","unstructured":"132. Taylor ED, Theim KR, Mirch MC, et al. Orthopedic complications of overweight in children and adolescents. Pediatrics. 2006; 117(6):2167-2174.10.1542\/peds.2005-1832186300716740861","DOI":"10.1542\/peds.2005-1832"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_133_w2aab3b7c13b1b6b1ab1ad133Aa","doi-asserted-by":"crossref","unstructured":"133. DiVall SA, Radovick S. Endocrinology of female puberty. Curr Opin Endocrinol Diabetes Obes. 2009;16(1):1-4.10.1097\/MED.0b013e3283207937","DOI":"10.1097\/MED.0b013e3283207937"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_134_w2aab3b7c13b1b6b1ab1ad134Aa","doi-asserted-by":"crossref","unstructured":"134. Coffield JE, Metos JM, Utz RL, Waitzman NJ. A multivariate analysis of federally mandated school wellness policies on adolescent obesity. J Adolesc Health. 2011;49(4):363-70.10.1016\/j.jadohealth.2011.01.01021939866","DOI":"10.1016\/j.jadohealth.2011.01.010"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_135_w2aab3b7c13b1b6b1ab1ad135Aa","doi-asserted-by":"crossref","unstructured":"135. Kalarchian MA, Levine MD, Arslanian SA, et al. Family-based treatment of severe pediatric obesity: randomized, controlled trial. Pediatrics. 2009;124(4):1060-1068.10.1542\/peds.2008-3727293549419786444","DOI":"10.1542\/peds.2008-3727"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_136_w2aab3b7c13b1b6b1ab1ad136Aa","doi-asserted-by":"crossref","unstructured":"136. Ortega FB, Labayen I, Ruiz JR, et al. Improvements in fitness reduce the risk of becoming overweight across puberty. Med Sci Sports Exerc. 2011;43(10):1891-1897.10.1249\/MSS.0b013e3182190d7121407124","DOI":"10.1249\/MSS.0b013e3182190d71"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_137_w2aab3b7c13b1b6b1ab1ad137Aa","doi-asserted-by":"crossref","unstructured":"137. Chang S-H, Stoll CRT, Song J, Varela E, Eagon CJ, Colditz G a. Bariatric surgery: an updated systematic review and meta analysis, 2003\u20132012. JAMA Surg. 2014;149(3):275-287.10.1001\/jamasurg.2013.3654396251224352617","DOI":"10.1001\/jamasurg.2013.3654"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_138_w2aab3b7c13b1b6b1ab1ad138Aa","doi-asserted-by":"crossref","unstructured":"138. Cummings DE, Overduin J, Foster-Schubert KE. Gastric Bypass for Obesity : Mechanisms of Weight Loss and Diabetes Resolution. J Clin Endocrinol Metab. 2015;89(6):2608-2615.10.1210\/jc.2004-043315181031","DOI":"10.1210\/jc.2004-0433"},{"key":"2026071212051946657_j_prilozi-2018-0013_ref_139_w2aab3b7c13b1b6b1ab1ad139Aa","doi-asserted-by":"crossref","unstructured":"139. Chapman AE, Hons BA, Kiroff G, Game P. Clinical review Laparoscopic adjustable gastric banding in the treatment of obesity : A systematic literature review. Surgery. 2004;153(3):326-351.10.1016\/S0039-6060(03)00392-1","DOI":"10.1016\/S0039-6060(03)00392-1"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/prilozi\/38\/3\/article-p121.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2018-0013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:03:32Z","timestamp":1783904612000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2018-0013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":139,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,4,16]]},"published-print":{"date-parts":[[2017,12,1]]}},"alternative-id":["10.2478\/prilozi-2018-0013"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2018-0013","relation":{},"ISSN":["1857-8985","1857-9345"],"issn-type":[{"value":"1857-8985","type":"electronic"},{"value":"1857-9345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}